PSORIATIC ARTHRITIS

This study tests a new drug called TQH3906 for people with active psoriatic arthritis, a condition causing joint pain and skin patches. About 156 adults aged 18-70 will receive either the new drug, a placebo, or an active comparator to see if it reduces symptoms like joint swelli…

This study compares two treatments for psoriatic arthritis: apremilast plus methotrexate versus adalimumab plus methotrexate. It will include 60 adults who did not get enough relief from methotrexate alone. The goal is to see which combination better controls joint and skin sympt…

This study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can reduce chronic pain in people with psoriatic arthritis who still hurt even when their joint inflammation is under control. Researchers will give 40 a…

This study looks at whether 12 weeks of high-intensity interval training and strength training can improve heart function, metabolism, and inflammation in people with psoriatic arthritis. About 88 adults aged 18-65 with stable medication will participate. The goal is to see if ex…

This study looks at whether people with rheumatic diseases (like rheumatoid arthritis or ankylosing spondylitis) have higher levels of harmful molecules called AGEs compared to healthy people. AGEs build up over time and can cause inflammation. Researchers will use a non-invasive…

This study aims to find early signs of psoriatic arthritis in people who have psoriasis but not yet arthritis. About 3,458 adults across Europe will use a smartphone app and optional smartwatch to track health data. The goal is to develop digital tools that can predict arthritis …

This study observes 30 adults in Mexico who are already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans, heart CT scans, and body composition tests to see how the drug affects knee cartilage, heart fat, and overall body health over one y…